Cardio Diagnostics Holdings is trading 6% up at $2.12 after rising from the September 15 close of $2.00, with no clear company-specific catalyst identified.
- No clear company-specific announcement, earnings release, or regulatory catalyst dated September 16, 2026 was identified.
- The latest notable company news was the August 18 laboratory launch.
- The broader market is modestly higher, but provided index gains remain below the 0.5% threshold for attributing this move to global sentiment.